2007-08-22T00:00:00
The National Institute for Health and Clinical Excellence has approved the drug rituximab (Mabthera) for patients with severe arthritis in England and Wales.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud